Cargando…

Targeting and limiting surgery for patients with node-positive breast cancer

The presence of axillary nodal metastases has a significant impact on locoregional and systemic treatment decisions. Historically, all node-positive patients underwent complete axillary lymph node dissection; however, this paradigm has changed over the last 10 years. The use of sentinel lymph node d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caudle, Abigail S., Kuerer, Henry M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481081/ https://www.ncbi.nlm.nih.gov/pubmed/26109042 http://dx.doi.org/10.1186/s12916-015-0385-5

Ejemplares similares

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
por: van la Parra, Raquel F. D., et al.
Publicado: (2016)

De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer
por: Tasoulis, Marios-Konstantinos, et al.
Publicado: (2022)

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
por: Pant, Shubham, et al.
Publicado: (2008)

Axillary surgery in node-positive breast cancer()
por: Maggi, Nadia, et al.
Publicado: (2021)

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
por: Lari, Sara A., et al.
Publicado: (2011)

Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes
por: Aragon-Sanchez, Sofia, et al.
Publicado: (2022)

Establishing a Program for Individuals at High Risk for Breast Cancer
por: Cadiz, Fernando, et al.
Publicado: (2013)

Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'
por: Kuerer, Henry M, et al.
Publicado: (2016)

The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer
por: Kay, Charlene, et al.
Publicado: (2023)

Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
por: Schmidt-Hansen, Mia, et al.
Publicado: (2016)

Axillary management in early breast cancer with onset surgical management and positive sentinel lymph node
por: Vasquez, Lia Pamela Rebaza, et al.
Publicado: (2021)

Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review
por: Lovrics, Olivia, et al.
Publicado: (2023)

The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic
por: Kuerer, Henry M., et al.
Publicado: (2020)

Effectiveness and Safety of Magseed Localization for Excision of Breast Lesions: A Prospective, Phase IV Trial
por: Singh, Puneet, et al.
Publicado: (2020)

State of the Science and the Intraductal Approach for Breast Cancer: Proceedings Summary of The Sixth International Symposium on the Intraductal Approach To Breast Cancer Santa Monica, California, 19–21 February 2009
por: Rochman, Susan, et al.
Publicado: (2009)

The Clinical Relevance of Target Lymph Node Biopsy after Primary Systemic Therapy in Initially Node-Positive Breast Cancer Patients
por: Hartmann, Steffi, et al.
Publicado: (2021)

Clinical Utility of Genomic Assay in Node-Positive Early-Stage Breast Cancer
por: Pauls, Mehrnoosh, et al.
Publicado: (2022)

Tailored axillary surgery – A novel concept for clinically node positive breast cancer
por: Heidinger, Martin, et al.
Publicado: (2023)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
por: diFlorio-Alexander, Roberta M., et al.
Publicado: (2021)

Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis
por: Ram, Rachna, et al.
Publicado: (2014)

Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer
por: Ladak, Farah, et al.
Publicado: (2022)

Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy
por: Chun, Jung Whan, et al.
Publicado: (2023)

Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients
por: Samiei, S., et al.
Publicado: (2019)

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
por: Van Wyhe, Renae D., et al.
Publicado: (2018)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer
por: Brufsky, Adam M.
Publicado: (2014)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation
por: Hirata, Kimiko, et al.
Publicado: (2017)

22nd Annual Virtual Meeting of the American Society of Breast Surgeons: Science, Innovation, and Practice Changes
por: Calvillo, Katherina Zabicki, et al.
Publicado: (2021)

Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis
por: Li, Yilun, et al.
Publicado: (2020)

Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients
por: Noguchi, Masakuni, et al.
Publicado: (2023)

The Role of the 21-Gene Recurrence Score(®) Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
por: Yordanova, Mariya, et al.
Publicado: (2022)

Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes
por: Kim, S I, et al.
Publicado: (2013)

Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer
por: Wu, Hao, et al.
Publicado: (2020)

The Synapse as a Central Target for Neurodevelopmental Susceptibility to Pesticides
por: Vester, Aimee, et al.
Publicado: (2016)

Marking Techniques for Targeted Axillary Dissection Among Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Gante, Inês, et al.
Publicado: (2023)

Targeted Axillary Dissection in Node-Positive Breast Cancer: A Retrospective Study and Cost Analysis
por: Beniey, Michèle, et al.
Publicado: (2021)

Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?
por: Taylor, Caitlin, et al.
Publicado: (2022)

Patterns of Cellular Distribution with the Sentinel Node Positive for Breast Cancer
por: Tsiapali, Ekaterini, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_meunvorj9d5jkdmj6gpcu5n8uc